Referencias:

• Bieniasz, P.D., Restriction factors: A defense against retroviral infection (2003) Trends Microbiol., 11 (6), pp. 286-291
• Wang, X., Hinson, E.R., Cresswell, P., The interferon-inducible protein viperin inhibits infuenza virus release by perturbing lipid rafts (2007) Cell Host Microbe, 2, pp. 96-105
• Seo, J.Y., Yaneva, R., Hinson, E.R., Cresswell, P., Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity (2011) Science, 332, pp. 1093-1097
• Lazear, H.M., Diamond, M.S., New insights into innate immune restriction of west nile virus infection (2015) Curr. Opin. Virol., 11, pp. 1-6
• Zhou, L.Y., Zhang, L.L., Host restriction factors for hepatitis C virus (2016) World J. Gastroenterol., 22 (4), pp. 1477-1486
• Pan, X.B., Han, J.C., Cong, X., Wei, L., BST2/ tetherin inhibits dengue virus release from human hepatoma cells (2012) PLoS ONE, 7 (12), p. e51033
• Stetson, D.B., Medzhitov, R., Type 1 interferons in host defense (2006) Immunity, 25 (3), pp. 373-381
• Fink, J., Gu, F., Ling, L., Host gene expression profling of dengue virus infection in cell lines and patients (2007) PLoS Negl. Trop. Dis., 1 (2), p. e86
• Jiang, D., Weidner, J.M., Qing, M., Identifcation of fve interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections (2010) J. Virol., 84, pp. 8332-8341
• Brass, A.L., Huang, I.C., Benita, Y., The IFITM proteins mediate cellular resistance to infuenza A H1N1 virus, West Nile virus, and dengue virus (2009) Cell, 139, pp. 1243-1254
• Lu, M.Y., Liao, F., Interferon-stimulated gene ISG12b2 is localized to the inner mitochondrial membrane and mediates virus-induced cell death (2011) Cell Death Differ., 18, pp. 925-936
• Dai, J., Pan, W., Wang, P., ISG15 facilitates cellular antiviral response to dengue and West Nile virus infection in vitro (2011) Virol. J., 8, p. 468
• Tay, M.Y., Fraser, J.E., Chan, W.K., Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; Protection against all 4 DENV serotypes by the inhibitor ivermectin (2013) Antiviral Res., 99 (3), pp. 301-306
• Sangiambut, S., Keelapang, P., Aaskov, J., Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection (2008) J. Gen. Virol., 89, pp. 1254-1264
• De Maio, F.A., Risso, G., Iglesias, N.G., The dengue virus NS5 protein intrudes in the cellular spliceosome and modulates splicing (2016) PLoS Pathog., 12 (8), p. e1005841
• Hannemann, H., Sung, P.Y., Chiu, H.C., Serotype-specifc differences in dengue virus non-structural protein 5 nuclear localization (2013) J. Biol. Chem., 288, pp. 22621-22635
• Van Damme, E., Laukens, K., Dang, T.H., Van Ostade, X., A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics (2010) Int. J. Biol. Sci., 6, pp. 51-67
• Giovannoni, F., Damonte, E.B., García, C.C., Cellular promyelocytic leukemia protein is an important dengue virus restriction factor (2015) PLoS ONE, 10 (5), p. e0125690
• Chiu, M.W., Shih, H.M., Yang, T.H., Yang, Y.L., The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifer-1 (SUMO-1) conjugating enzyme 9 (Ubc9) (2007) J. Biomed. Sci., 14 (3), pp. 429-444
• Su, C.I., Tseng, C.H., Yu, C.Y., Lai, M.M., SUMO modifcation stabilizes dengue virus nonstructural protein 5 to support virus replication (2016) J. Virol., 90 (9), pp. 4308-4319

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------